AntineoplasticsPneumocystis jirovecii pneumonia and pneumonia: 2 case reports

被引：0

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1725卷 / 1期

关键词：

D O I：

10.1007/s40278-018-53377-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：36 / 36

相关论文

共 50 条

[21] Ciclosporin/rituximabPneumocystis jirovecii pneumonia: 2 case reports [J].

Reactions Weekly, 2019, 1763 (1) :102-102

[22] IdelalisibPneumocystis jirovecii pneumonia, pneumonia and pneumonitis: 3 case reports [J].

Reactions Weekly, 2022, 1924 (1) :246-246

[23] AntineoplasticsPneumocystis pneumonia: case report [J].

Reactions Weekly, 2021, 1836 (1) :92-92

[24] AntineoplasticsPneumocystis pneumonia: case report [J].

Reactions Weekly, 2016, 1583 (1) :114-114

[25] ImmunosuppressantsPneumocystis jirovecii pneumonia: 9 case reports [J].

Reactions Weekly, 2020, 1820 (1) :161-161

[26] BendamustinePneumocystis jirovecii pneumonia: 8 case reports [J].

Reactions Weekly, 2022, 1910 (1) :109-109

[27] EtanerceptPneumocystis jirovecii pneumonia: 15 case reports [J].

Reactions Weekly, 2013, 1440 (1) :18-18

[28] ImmunosuppressantsPneumocystis jirovecii pneumonia: 5 case reports [J].

Reactions Weekly, 2021, 1868 (1) :215-215

[29] AdalimumabPneumocystis jirovecii pneumonia: 17 case reports [J].

Reactions Weekly, 2015, 1548 (1) :13-13

[30] EverolimusPneumocystis jirovecii pneumonia: 3 case reports [J].

Reactions Weekly, 2015, 1547 (1) :124-124

← 1 2 3 4 5 →